Chronic Enteropathy In Canines: Prevalence, Impact And Management Strategies
- PMID: 31828025
- PMCID: PMC6902862
- DOI: 10.2147/VMRR.S162774
Chronic Enteropathy In Canines: Prevalence, Impact And Management Strategies
Abstract
In this article, the studies about the prevalence of chronic enteropathy are reviewed as well as the information regarding short- and long-term prognosis for dogs treated with the three most common therapies; these include dietary modification, antibiotics, and immunosuppressants. Although the data available are limited, most studies support a good to excellent long-term response in dogs that have a successful food trial, whereas the response is poor with antibiotics or on-going treatment is required to retain remission. There is a risk of antimicrobial resistance developing with inappropriate use of antimicrobials such as in these situations. The published information highlights the need for alternative strategies to antibiotic treatment to manipulate the GI microbiome, and in the final part of this article studies on the use of probiotic for the treatment of chronic enteropathy are reviewed.
Keywords: chronic enteropathy; diet; dog; inflammatory bowel disease; probiotic; treatment.
© 2019 Dandrieux and Mansfield.
Conflict of interest statement
The authors report no conflicts of interest in this work.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
